Pharming Group N.V. (PHAR)

Pharming Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	585	753	716	571	970	-
Market Cap Growth	-17.90%	5.29%	25.30%	-41.09%	-	-
Enterprise Value	539	707	672	537	946	26
PE Ratio	-	-64.29	49.19	31.42	21.06	-
PS Ratio	2.06	2.76	3.27	2.53	3.75	-
PB Ratio	2.57	3.10	3.29	2.61	4.33	-
P/FCF Ratio	-193.09	-36.19	31.91	18.54	10.07	-
P/OCF Ratio	-309.26	-39.19	29.95	13.28	9.51	-
EV/Sales Ratio	1.92	2.59	3.07	2.38	3.66	0.12
EV/EBITDA Ratio	65.35	162.59	22.42	11.07	14.81	0.40
EV/EBIT Ratio	-53.04	-52.97	42.15	20.47	17.60	0.44
EV/FCF Ratio	-183.06	-33.95	29.97	17.43	9.83	0.32
Debt / Equity Ratio	0.81	0.78	0.81	0.84	1.02	0.83
Debt / EBITDA Ratio	22.06	43.84	5.92	3.79	3.57	1.68
Debt / FCF Ratio	-48.24	-9.15	7.91	5.97	2.37	1.36
Quick Ratio	1.16	3.33	3.94	4.75	3.15	0.90
Current Ratio	1.43	4.06	4.65	5.33	3.43	1.05
Asset Turnover	0.58	0.56	0.52	0.51	0.63	0.81
Return on Equity (ROE)	-5.20%	-5.10%	6.80%	8.60%	25.10%	45.30%
Return on Assets (ROA)	-2.40%	-2.40%	3.40%	4.10%	11.20%	17.20%
Return on Capital (ROIC)	-2.15%	-1.38%	4.48%	2.65%	17.61%	24.62%
Earnings Yield	-2.03%	-1.56%	2.03%	3.18%	4.75%	-
FCF Yield	-0.65%	-2.76%	3.13%	5.39%	9.93%	-
Buyback Yield / Dilution	-2.24%	-1.61%	-1.55%	-0.12%	-	-
Total Shareholder Return	-2.24%	-1.61%	-1.55%	-0.12%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).